varicella-zoster%20virus%20infection%20(pediatric)
VARICELLA-ZOSTER VIRUS INFECTION (PEDIATRIC)
Varicella, also known as chickenpox, is a self-limited, benign disease caused by primary varicella-zoster virus (VZV) infection characterized by fever, malaise, and generalized pruritic vesicular rash.
The average incubation period is 14-16 days. It is transmitted via direct contact with vesicular fluid or inhalation of aerosolized respiratory secretions or via droplet route during face to face contact.
Hallmark sign is pruritic rash that begins in the scalp and face which eventually spreads to the trunks and extremities.

Pharmacotherapy

Symptomatic Therapy

Antipruritics

  • Calamine lotion, tepid baths, cool compresses

Antipyretics

  • Eg Paracetamol
    • Aspirin should not be used in children because of its association w/ Reye’s syndrome
  • Provide symptomatic relief of fever

Analgesics

  • Eg Paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs); opioids may be considered in severe pain
  • May be used for relief of pain in herpes zoster infections

Corticosteroids

  • Benefits include acute pain reduction & rapid early healing
  • Should be administered w/ antiviral therapy due to its immunosuppressive properties
    • Concomitant use does not reduce incidence of postherpetic neuralgia (PHN)

Antivirals for varicella

  • In otherwise healthy children, varicella is often benign & requires symptomatic care only
  • Varicella in otherwise healthy adolescents & in immunocompromised patients tends to be more severe & they may be treated w/ antivirals preferably w/in 24 hours

Aciclovir (PO/IV)

  • Aciclovir is recommended in VZV infections in immunocompromised patients
    • May be considered in patients w/ chronic cutaneous disorders, in patients w/ diseases that can be exacerbated by VZV infection (eg cystic fibrosis), otherwise healthy patients >12 years old or secondary household contacts, adolescents & adults
  • IV therapy should be used in severely immunocompromised patients & in severe infections
    • High-dose oral Aciclovir may be sufficient for mildly immunocompromised patients
  • Aciclovir is a guanosine analogue that is a competitive inhibitor of viral DNA polymerase
    • Limits viral replication & stops further spread of the virus to other cells
  • Shortens the duration of viral shedding, halts the formation of new lesions more quickly, accelerates the rate of healing in both immunocompetent & immunocompromised patients
    • This improvement is modest in the healthy individual but can reduce life-threatening complications in high-risk individuals

Famciclovir/Valaciclovir

  • Have been used in place of Aciclovir in otherwise healthy adolescents

Antivirals for herpes zoster

  • Oral antiviral therapy is recommended in immunocompetent patients w/ ophthalmic rash, patients ≥50 years old, & in patients suffering moderate to severe pain
  • Intravenous (IV) Aciclovir is typically recommended in immunocompromised patients
    • Oral antivirals may be acceptable in patients who are only mildly to moderately immunocompromised 
  • Primary goal of treatment in herpes zoster is to reduce acute pain & PHN
  • Therapy for herpes zoster should accelerate healing; limit the severity & duration of acute & chronic pain; reduce complications
  • When taken w/in 72 hours of symptom onset, oral antivirals have been shown to reduce severity & duration of symptoms
    • Most virus replication has ceased by 72 hours after the onset of rash but this may be substantially extended in immunocompromised patients
    • After 72 hours, antivirals should be considered if new vesicular lesions are continuing to appear 
  • Choice of agent depends on availability, cost, dosing schedule & patient preference

Aciclovir

  • Guanosine analogue that is a competitive inhibitor of viral DNA polymerase
    • Limits viral replication & stops further spread of the virus to other cells
  • Several studies have shown that high-dose oral Aciclovir accelerates resolution of acute lesions & may reduce the risk for prolonged pain

Alternative Treatment for Herpes Zoster

Brivudine (Brivudin)

  • Actions: A thymidine nucleoside analogue that competitively inhibits viral DNA replication by blocking DNA polymerases
  • Brivudine is a treatment option for immunocompetent patients w/ herpes zoster
  • Effects: Several studies have shown that patients given Brivudine had shorter time to last new-lesion formation & full crusting, & w/ less experienced pain
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elaine Soliven, 17 Aug 2017
Probiotic supplementation during the first 6 months of life does not reduce the incidence of eczema or asthma later in childhood, according to the randomized controlled TIPS* study.